Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
企業コードSEER
会社名Seer Inc
上場日Dec 04, 2020
最高経営責任者「CEO」Farokhzad (Omid C)
従業員数134
証券種類Ordinary Share
決算期末Dec 04
本社所在地3800 Bridge Parkway, Suite 102
都市REDWOOD CITY
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号94065
電話番号16504530000
ウェブサイトhttps://seer.bio/
企業コードSEER
上場日Dec 04, 2020
最高経営責任者「CEO」Farokhzad (Omid C)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし